Scout24 Stock (OTC:SCCTY), Trade Ideas

Scout24 SE is an innovative digital company that operates ImmoScout24, the platform for residential and commercial real estate in Germany. With ImmoScout24, it has been successfully bringing together owners, agents, tenants, and buyers for about 25 years. Through its know-how and its diverse services, it ensures transparency in the market and makes complex decisions easy for its users. So that users can process real estate transactions completely digitally in the long term, ImmoScout24 is building an ecosystem for purchase, rental and commercial real estate.

Scout24 SE

In the latest development, a key ally of Russian President Vladimir Putin has cautioned that Russia could retaliate harshly if the West proceeds with the seizure of nearly $300 billion of frozen Russian assets to assist Ukraine.
What Happened: Valentina Matviyenko, the speaker of the Russian upper house of parliament, announced on Tuesday that Russia is ready to react strongly if its frozen assets are seized, CNBC <a href="https://www.cnbc.com/2024/04/23/ukraine-war-live-updates-latest-news-on-russia-and-the-war-in-ukraine.html">reported</a> on Monday. Matviyenko, who is also a member of Russia's Security Council, disclosed that a draft law on response measures has been prepared, but did not elaborate on the potential retaliatory actions.
The proposal to seize frozen Russian assets abroad is still under discussion among Western officials. A large chunk of these assets, around $224 billion, are situated in the European Union, as per a Russian lawmaker. The United States holds a comparatively smaller amount of these assets, valued between $5 and $6 billion.
See Also: <a href="https://www.benzinga.com/news/24/04/38356833/liz-cheney-says-trump-doing-everything-possible-to-postpone-jan-6-case-beyond-election-deep-flaws-in?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Liz Cheney Says Trump &#8216;Doing Everything Possible&#8217; To Postpone Jan. 6 Case Beyond Election: &#8216;Deep Flaws In Character&#8230;Make Him Unfit To Serve As President</a>
Why It Matters: The seizure of these assets could heighten tensions between Russia and the West, possibly triggering further conflict. This development follows the ongoing disputes between Russia and Ukraine, with Russia asserting to have captured a second eastern Ukrainian village within two days, a claim Ukraine refutes.
Earlier this year, Ursula von der Leyen, the European Commission President, suggested using Russia's <a href="https://www.benzinga.com/news/24/03/37421177/russias-frozen-assets-should-be-used-to-arm-ukraine-says-european-commission-president">frozen assets to provide military support </a>to Ukraine, which is grappling with a severe ammunition shortage due to Russia's military aggression.
Moreover, Russian Finance Minister Anton Siluanov expressed <a href="https://www.benzinga.com/news/24/02/37355108/russia-warns-of-eroding-trust-in-dollar-euro-over-potential-asset-seizure-to-aid-ukraine-the-reliabi">concerns about the trustworthiness </a>of the dollar and euro, attributing the decline to the ongoing discussions about the $300 billion in Russian assets that were frozen in response to the 2022 invasion of Ukraine.
Read Next: <a href="https://www.benzinga.com/news/24/04/38348277/trump-vs-biden-nationwide-poll-shows-key-issue-decidedly-tilts-equation-in-favor-of-one-candidate?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump vs. Biden: Nationwide Poll Shows Key Issue Decidedly Tilts Equation In Favor Of One Candidate</a>
Photo by Shag 7799 on Shutterstock
<div style="font-family: 'Lato', sans-serif">
<div>
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by Benzinga Neuro, Edited by 
 <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Pooja Rajkumari</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>
</div>

News

Politics

General

Russia Threatens Retaliation Over Potential Seizure Of Frozen Assets To Aid Ukraine

WIIM

AVTR

Avantor shares are trading higher in sympathy with Danaher, which reported better-than-expected Q1 financial results.

As of April 23, 2024, two stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.  
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Moolec Science SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLEC#NASDAQ">MLEC</a>)</h3>
<ul>
<li>On April 22, Moolec Science said it received approval for its plant-grown animal proteins. The Animal and Plant Health Inspection Service (APHIS) of the U.S. Department of Agriculture (USDA) has concluded its Regulatory Status Review (RSR) for Moolec's genetically engineered (GE) soybean Piggy Sooy. "We achieved an unprecedented milestone in biotechnology with the first-ever USDA-APHIS approval of this kind," stated CEO and Co-Founder Gastón Paladini. The company's stock gained around 106% over the past five days and has a <a href="https://www.benzinga.com/quote/MLEC">52-week high of $4.40</a>.</li>
<li>RSI Value: 71.26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>MLEC Price Action: Shares of Moolec Science jumped 79% to close at $2.47 on Monday.</li>
</ul>
<h3 class="wp-block-heading">Yatsen Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YSG#NYSE">YSG</a>)</h3>
<ul>
<li>On April 11, Yatsen regained compliance with NYSE minimum price continued listing criterion. The company's stock gained around 83% over the past month and <a href="https://www.benzinga.com/quote/YSG">has a 52-week high</a> of $6.65.</li>
<li>RSI Value: 79.76</li>
<li>YSG Price Action: Shares of Yatsen Holding gained 1.3% to close at $3.80 on Monday.</li>
</ul>
Also Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38370420/general-motors-tesla-and-3-stocks-to-watch-heading-into-tuesday">General Motors, Tesla And 3 Stocks To Watch Heading Into Tuesday</a>

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

MLEC

Top 2 Risk Off Stocks You May Want To Dump In Q2

JP Morgan analyst Cory Carpenter upgrades Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) from Neutral to Overweight and raises the price target from $41 to $48.

Upgrades

Price Target

Analyst Ratings

RBLX

JP Morgan Upgrades Roblox to Overweight, Raises Price Target to $48

Rosenblatt analyst Catharine Trebnick initiates coverage on NICE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NICE#NASDAQ">NICE</a>) with a Buy rating and announces Price Target of $285.

Initiation

NICE

Rosenblatt Initiates Coverage On NICE with Buy Rating, Announces Price Target of $285

OPRT

Oportun Financial shares are trading higher after the company announced preliminary Q1 total revenue above estimates.

First Commonwealth (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCF#NYSE">FCF</a>) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.36 by 2.78 percent. This is a 17.78 percent decrease over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $116.615 million which missed the analyst consensus estimate of $119.931 million by 2.77 percent. This is a 0.86 percent decrease over sales of $117.626 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

First Commonwealth Q1 2024 Adj EPS $0.37 Beats $0.36 Estimate, Sales $116.615M Miss $119.931M Estimate

AZTR

Azitra shares are trading higher after the company announced new preclinical data will be presented at the American Society of Gene and Cell Therapy meeting.

JAGX

Jaguar Health shares are trading lower after the company filed for a mixed shelf offering of up to $75 million.

Oppenheimer analyst Rupesh Parikh maintains Church &amp; Dwight Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHD#NYSE">CHD</a>) with a Outperform and raises the price target from $110 to $120.

Oppenheimer Maintains Outperform on Church & Dwight Co, Raises Price Target to $120

Program to expand from 10 patients to a total of 30 patients.

Biotech

TLSA

Tiziana Life Sciences Announces FDA Allowance For Additional Patients To Be Enrolled In Intranasal Foralumab Multiple Sclerosis Expanded Access Program

Oppenheimer analyst Suraj Kalia upgrades AtriCure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRC#NASDAQ">ATRC</a>) from Perform to Outperform and announces $32 price target.

ATRC

Oppenheimer Upgrades AtriCure to Outperform, Announces $32 Price Target

RBC Capital analyst Jon Arfstrom maintains Zions Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) with a Sector Perform and raises the price target from $46 to $47.

ZION

RBC Capital Maintains Sector Perform on Zions Bancorp, Raises Price Target to $47

ABEO

Abeona Therapeutics shares are trading lower after the company announced the FDA issued a Complete Response Letter in response to the company's Biologics License Application for pz-cel for the treatment of patients with recessive dystrophic epidermolysis bullosa.

RBC Capital analyst Steven Shemesh maintains Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) with a Outperform and lowers the price target from $23 to $22.

RBC Capital Maintains Outperform on Albertsons Companies, Lowers Price Target to $22

Cyngn shares are trading higher after the company announced that it has been chosen to supply its DriveMod Tuggers for industrial automation to John Deere's operation in Dubuque, Iowa.

NextEra Energy Q1 2024 Adj EPS $0.91 Beats $0.73 Estimate

Health Care

Contracts

THAR

Tharimmune Announced An Option Agreement For An Exclusive License With Washington University In St. Louis For Technology Related To Multiple Hybridomas And Antibodies Directed Specifically Towards Human HER2

ONTO

Onto Innovation Debuts Sub-surface Defect Inspection For Advanced Packaging

Webster Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WBS#NYSE">WBS</a>) reported quarterly earnings of $1.35 per share which missed the analyst consensus estimate of $1.41 by 4.26 percent. This is a 15.09 percent decrease over earnings of $1.59 per share from the same period last year. The company reported quarterly sales of $567.739 million which missed the analyst consensus estimate of $616.786 million by 7.95 percent. This is a 4.63 percent decrease over sales of $595.283 million the same period last year.

Webster Finl Q1 2024 Adj EPS $1.35 Misses $1.41 Estimate, Sales $567.739M Miss $616.786M Estimate

Scout24